Login to Your Account



Aptinyx refuels with $70M series B for NMDA modulators

By Marie Powers
News Editor

Monday, December 18, 2017

Aptinyx Inc. continued to race down the track by completing a $70 million series B financing to continue advancing its pipeline of NMDA receptor modulators.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription